Baby's own cord tissue used to patch spinal defect in promising new trial

NCT ID NCT06929572

Recruiting now Disease control Sponsor: The University of Texas Health Science Center, Houston Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a new surgical approach for newborns with spina bifida, where a patch made from the baby's own umbilical cord is used to cover the spinal defect shortly after birth. The goal is to see if this method reduces complications like wound breakdown and fluid leakage compared to standard care. Fifteen infants will be enrolled and followed for outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: autologous umbilical cord patch
What this could lead to: If successful, this could offer a safer, more effective way to repair spinal defects in newborns with spina bifida, potentially reducing complications like spinal cord tethering.
What could go wrong: This is a very small early-stage trial with only 15 participants, so results may not apply to all. Risks include infection, wound breakdown, or cerebrospinal fluid leakage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYELOSCHISIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myelomeningocele myeloschisis neural tube defect spina bifida

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SPINA BIFIDA

Contacts and locations

Locations

The University of Texas Health Science Center at Houston
RECRUITING

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.